Business Context and Reporting Period
Company: Hyster-Yale, Inc.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2025
Business Overview: The Company designs, manufactures, and sells lift trucks, attachments, and aftermarket parts globally under the Hyster and Yale brands. It operates through four segments: Americas, EMEA, JAPIC, and Bolzoni. In Q2 2025, the Company merged Nuvera Fuel Cells into the Americas segment and completed a $2.6 million acquisition by Bolzoni in Italy.
Key Financial Metrics
| Metric (in millions) | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Revenues | $956.6 | $1,168.1 | $1,867.0 | $2,224.6 |
| Gross Profit | $168.2 | $259.3 | $345.9 | $495.0 |
| Gross Margin | 17.6% | 22.2% | 18.5% | 22.3% |
| Operating Profit (Loss) | $(8.5) | $95.6 | $12.8 | $179.4 |
| Net Loss Attributable to Stockholders | $(13.9) | $63.3 | $(5.3) | $114.8 |
| Diluted EPS | $(0.79) | $3.58 | $(0.30) | $6.51 |
| Cash and Cash Equivalents | $66.9 | $96.6 | $66.9 | $78.8 |
| Total Debt (Short + Long Term) | $378.8 | $396.1 | $378.8 | $396.1 |
| Operating Cash Flow (YTD) | $(7.5) | $19.9 | $(7.5) | $19.9 |
Material Changes vs. Prior Period
- Revenue Decline: Q2 2025 revenues decreased 18.1% year-over-year, driven by a 19.1% drop in lift truck volumes and a shift to lower-priced products, particularly in the Americas and EMEA. YTD revenue declined 16.1%.
- Profitability Collapse: Operating profit swung from a $95.6 million profit in Q2 2024 to an $8.5 million loss in Q2 2025. This was caused by lower gross margins (due to volume, tariffs, and material costs) and $15.7 million in restructuring and impairment charges.
- Restructuring Charges: The Company recognized $15.7 million in Q2 2025 restructuring and impairment charges, primarily related to the strategic realignment of Nuvera Fuel Cells ($15.2 million) and ongoing manufacturing footprint optimization programs.
- Segment Performance:
- Americas: Operating profit dropped 87.4% to $11.7 million due to volume declines and restructuring charges.
- EMEA: Turned to an operating loss of $15.0 million from a $4.8 million profit, driven by lower margins and unfavorable pricing.
- JAPIC: Operating loss widened to $7.6 million due to manufacturing inefficiencies and currency impacts.
- Cash Flow: Operating cash flow turned negative at $(7.5) million YTD 2025 compared to $19.9 million in YTD 2024, largely due to the net loss and higher employee-related payments.
Guidance, Outlook, and Risks
- Outlook Revision: Management anticipates a decline in full-year 2025 operating profit relative to prior guidance due to reduced bookings, lower production volumes, and tariff impacts.
- Tariff Impact: The Company expects tariffs to negatively affect financial results in the second half of 2025. While price increases and sourcing adjustments are being implemented, they may not fully offset costs immediately.
- Bookings and Backlog: Q2 2025 bookings dropped to $330 million (down from $590 million in Q1 2025) due to tariff uncertainty. Backlog stands at $1.65 billion, down from $1.9 billion in Q1.
- Cost Optimization: Restructuring programs initiated in 2024 are expected to generate $30 million to $40 million in annualized savings starting in 2027. Nuvera realignment is expected to yield $15 million to $20 million in annualized cost reductions in H2 2025.
- Capital Expenditures: Full-year 2025 CapEx is forecasted between $50 million and $60 million.
- Risks: Key risks include global trade barriers, geopolitical instability (Red Sea, Russia/Ukraine), supply chain disruptions, and the ability of customers to access credit.
Investor Verification Checklist
- Tariff Mitigation: Verify the effectiveness of price increases and supply chain adjustments in offsetting the projected tariff costs for H2 2025.
- Restructuring Execution: Monitor the timeline and cost realization of the Nuvera realignment and manufacturing footprint optimization programs.
- Booking Trends: Track Q3 2025 booking levels to confirm if the anticipated sequential growth materializes amidst economic uncertainty.
- Liquidity Position: Review the utilization of the $300 million revolving credit facility and the impact of negative operating cash flow on working capital management.
- Inventory Levels: Assess inventory optimization efforts given the $776.6 million inventory balance and the risk of further impairment charges if demand does not recover.